Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.

Slides:



Advertisements
Similar presentations
European Urology Focus
Advertisements

74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.
Volume 64, Issue 3, Pages (September 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)
Volume 60, Issue 5, Pages (November 2011)
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
Volume 70, Issue 1, Pages (July 2016)
Volume 67, Issue 3, Pages (March 2015)
European Urology Oncology
Volume 69, Issue 1, Pages (January 2016)
Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis  Alexey Surov, Hans Jonas.
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 71, Issue 4, Pages (April 2017)
European Urology Oncology
Volume 63, Issue 6, Pages (June 2013)
Volume 71, Issue 3, Pages (March 2017)
European Urology Oncology
European Urology Oncology
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Volume 69, Issue 4, Pages (April 2016)
Volume 71, Issue 6, Pages (June 2017)
Prostate Cancer Epidemic in Sight?
Yuanshan Cui, Yong Zhang  European Urology 
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers  Pasquale Rescigno, David Lorente, David Dolling, Roberta Ferraldeschi, Daniel.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 66, Issue 2, Pages (August 2014)
Volume 62, Issue 4, Pages (October 2012)
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,
Volume 71, Issue 1, Pages (January 2017)
European Urology Oncology
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
European Urology Oncology
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
Prostate Cancer Nomograms: An Update
European Urology Oncology
European Urology Oncology
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Correlation of apparent diffusion coefficient ratio on 3
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
How and When to Take Prostate Biopsies
European Urology Oncology
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
The Cost to Medicare of Bladder Cancer Care
European Urology Oncology
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
European Urology Oncology
Axel Heidenreich  European Urology Supplements 
European Urology Oncology
European Urology Oncology
Volume 54, Issue 3, Pages (September 2008)
Axel Heidenreich  European Urology Supplements 
European Urology Oncology
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
Presentation transcript:

Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas Wienke  European Urology Oncology  DOI: 10.1016/j.euo.2018.12.006 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Flowchart of the data acquisition. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 Forest plots of correlation coefficients between ADC and Gleason score in all involved studies. ADC=apparent diffusion coefficient; CI=confidence interval; IV=interval variable; SE=standard error. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 3 Forest plots of correlation coefficients between ADC and Gleason score in PC located in the peripheral zone. ADC=apparent diffusion coefficient; CI=confidence interval; IV=interval variable; PC=prostate cancer; SE=standard error. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 4 Forest plots of correlation coefficients between ADC and Gleason score in PC located in the transitional zone. ADC=apparent diffusion coefficient; CI=confidence interval; IV=interval variable; PC=prostate cancer; SE=standard error. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 5 Forrest plots of correlation coefficients between ADC and Gleason score estimated on surgical specimens. ADC=apparent diffusion coefficient; CI=confidence interval; IV=interval variable; SE=standard error. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 6 Forrest plots of correlation coefficients between ADC and Gleason score estimated on bioptic specimens. ADC=apparent diffusion coefficient; CI=confidence interval; IV=interval variable; SE=standard error. European Urology Oncology DOI: (10.1016/j.euo.2018.12.006) Copyright © 2019 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.